Ozdemir Ozdemir, Altintas Ozgul, Altintas Levent, Ozkan Berna, Akdag Cigdem, Yüksel Nurşen
Ophthalmology Department, Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, Turkey.
Ophthalmology Department, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
Arq Bras Oftalmol. 2014 Aug;77(4):209-13. doi: 10.5935/0004-2749.20140054.
To compare the effects of bevacizumab applied either subconjunctivally or topically, in a rat model of corneal neovascularization induced by alkali burn.
The right corneas of 24 Wistar-Albino rats were cauterized with silver nitrate sticks. The rats were divided randomly and equally into three groups: no treatment control (n=8), subconjunctival bevacizumab treatment (n=8), and topical bevacizumab treatment (n=8). Immediately following cauterization, the subconjunctival group was treated with a 0.05 ml (1.25 mg) bevacizumab subconjunctival injection. The topical group was treated with 10 mg/ml bevacizumab twice daily, and the control group received subconjunctival saline injections twice daily. The burn stimulus and neovascularization scores were evaluated using a technique previously described by Mahoney and Waterbury. Digital photographs were obtained before the eyes were enucleated and corneal sections were then analyzed by histopathology.
The mean burn stimulus score was 1.86 ± 0.6 and there was no statistical difference between the groups (p=0.730). The mean neovascularization scores in the subconjunctival and topical bevacizumab groups were statistically lower than the control group (p<0.05). The mean percentage area of corneal neovascularization was 82.5 ± 22.1 in the control group, 42.7 ± 15.0 in the subconjunctival group, and 55.8 ± 18.2 in the topical group. The differences between the control and treatment groups were statistically significant (p<0.05). Histopathology showed that the treatment groups presented less neovascularization, inflammation, and fibroblast activity than the control group (p<0.05).
This study demonstrates that both subconjunctival and topical administrations of bevacizumab inhibit corneal neovascularization and decrease inflammation and fibroblast activity in a rat model of corneal neovascularization induced by alkali burn.
在碱烧伤诱导的大鼠角膜新生血管模型中,比较结膜下注射与局部应用贝伐单抗的效果。
用硝酸银棒烧灼24只Wistar - 白化大鼠的右眼。将大鼠随机等分为三组:未治疗对照组(n = 8)、结膜下注射贝伐单抗治疗组(n = 8)和局部应用贝伐单抗治疗组(n = 8)。烧灼后立即对结膜下注射组进行0.05 ml(1.25 mg)贝伐单抗结膜下注射治疗。局部应用组每天用10 mg/ml贝伐单抗治疗两次,对照组每天进行两次结膜下生理盐水注射。使用Mahoney和Waterbury先前描述的技术评估烧伤刺激和新生血管评分。在摘除眼球前获取数码照片,然后通过组织病理学分析角膜切片。
平均烧伤刺激评分为1.86±0.6,各组间无统计学差异(p = 0.730)。结膜下注射和局部应用贝伐单抗组的平均新生血管评分在统计学上低于对照组(p<0.05)。对照组角膜新生血管的平均面积百分比为82.5±22.1,结膜下注射组为42.7±15.0,局部应用组为55.8±18.2。对照组与治疗组之间的差异具有统计学意义(p<0.05)。组织病理学显示,治疗组的新生血管形成、炎症和成纤维细胞活性均低于对照组(p<0.05)。
本研究表明,在碱烧伤诱导的大鼠角膜新生血管模型中,结膜下注射和局部应用贝伐单抗均可抑制角膜新生血管形成,并减少炎症和成纤维细胞活性。